ERS 2025: APG808 to address need for biologic for moderate asthma

"ERS 2025: APG808 to address need for biologic for moderate asthma" was originally created and published by Pharmaceutical ...
Healio

Biologics therapy may lead to greater asthma remission in non-white patients

Please provide your email address to receive an email when new articles are posted on . Biologic therapies are underutilized in non-white populations. By identifying barriers to specific biologic ...
Pulmonology Advisor

Biologics Have Similar Effectiveness Improving Lung Function in Severe Asthma

The biologics omalizumab, mepolizumab, benralizumab, and dupilumab have similar effectiveness in improving lung function in severe asthma.
The American Journal of Managed Care

New Insight on Biologic Initiation Patterns for Treating Severe Asthma

There are clear benefits to starting biologic therapy earlier for severe asthma, as well as initiation patterns by ethnicity, ...
The American Journal of Managed Care

Biologics’ Efficacy in Severe, Uncontrolled Asthma Associated With Higher Blood Eosinophil Count

Higher baseline blood eosinophil count was linked to improvement in asthma exacerbations and overall better outcomes seen with biologic therapies. Biologics’ efficacy in patients with severe, ...
Monthly Prescribing Reference

Current and Future Biologics for Severe Allergic Asthma in Children Over 6 Years

Improved understanding of asthma endotypes, reflecting pathological processes that underlie asthma phenotypes, has informed the development of add-on biologic therapies for severe, treatment-resistant ...
Healio

Dupilumab outperforms other biologics in reducing asthma exacerbation rate

Please provide your email address to receive an email when new articles are posted on . Patients with difficult-to-control asthma had reduced asthma exacerbation rates with dupilumab vs. benralizumab ...
clinicaladvisor.com

Biologics Improve Outcomes in Severe Asthma, Regardless of Age

Results showed annualized asthma exacerbation rates were reduced in all age groups 6 months after compared with 6 months before initiating a biologic. Among patients with severe asthma, treatment with ...
Monthly Prescribing Reference

Initiate Biologic Therapy Sooner in Uncontrolled Severe Asthma?

In CHRONICLE, researchers examined associations between exacerbations and initiation of biologic therapy in patients with uncontrolled severe asthma. The following article features coverage from the ...
Medscape

Physicians Urged to Monitor Asthma Patients on Biologics for Remission and Potential EGPA Symptoms During Steroid Tapering

VIENNA — Physicians are called to record clinical details of patients with asthma undergoing biologic therapy to monitor clinical remission and keep an eye on eosinophilic granulomatosis with ...
MedPage Today on MSN

One Biologic Comes Out on Top in Chronic Rhinosinusitis With Nasal Polyps and Asthma

The first head-to-head randomized clinical trial to compare biologics in severe chronic rhinosinusitis with nasal polyps ...
Medical Dialogues

Dupilumab Outperforms Omalizumab in First Head-to-Head Trial for Severe CRSwNP with Asthma: Study

The EVEREST trial directly compared biologics in severe chronic rhinosinusitis with nasal polyps (CRSwNP) and coexisting ...